Tvardi Therapeutics (TVRD) Change in Taxes: 2013-2017
Historic Change in Taxes for Tvardi Therapeutics (TVRD) over the last 5 years, with Dec 2017 value amounting to $26,000.
- Tvardi Therapeutics' Change in Taxes fell 86.24% to $26,000 in Q4 2017 from the same period last year, while for Dec 2017 it was -$121,000, marking a year-over-year decrease of 125.85%. This contributed to the annual value of -$697,000 for FY2024, which is N/A change from last year.
- Per Tvardi Therapeutics' latest filing, its Change in Taxes stood at $26,000 for Q4 2017, which was down 82.07% from $145,000 recorded in Q3 2017.
- In the past 5 years, Tvardi Therapeutics' Change in Taxes registered a high of $200,000 during Q3 2015, and its lowest value of -$294,000 during Q1 2017.
- In the last 3 years, Tvardi Therapeutics' Change in Taxes had a median value of $45,000 in 2015 and averaged $44,250.
- Within the past 5 years, the most significant YoY rise in Tvardi Therapeutics' Change in Taxes was 3,600.00% (2014), while the steepest drop was 314.29% (2014).
- Quarterly analysis of 5 years shows Tvardi Therapeutics' Change in Taxes stood at $3,000 in 2013, then soared by 3,600.00% to $111,000 in 2014, then tumbled by 159.46% to -$66,000 in 2015, then spiked by 386.36% to $189,000 in 2016, then crashed by 86.24% to $26,000 in 2017.
- Its Change in Taxes stands at $26,000 for Q4 2017, versus $145,000 for Q3 2017 and $2,000 for Q2 2017.